InJe University Sanggye Paik Hospital, Seoul, South Korea.
National Evidence-based Healthcare Collaborating Agency, Seoul, South Korea.
Eur J Phys Rehabil Med. 2020 Aug;56(4):489-495. doi: 10.23736/S1973-9087.20.06081-5. Epub 2020 May 8.
The participation rate for cardiac rehabilitation (CR) remains low in some Europe and Asia including Korea.
To investigate effects of CR on prognosis improvements in terms of recurrence, readmission, revascularization, and mortality rates in patients with acute myocardial infarction (AMI) in Korea.
A retrospective cohort study.
Eleven Tertiary Hospitals In Korea (ETHIK Study).
Data from a total of 7299 patients between January 2012 and December 2015 were collected, of which data from 7136 patients were linked to insurance claims data. In the final analysis, 6743 patients were included.
Patients who participated in the CR program while receiving outpatient treatment were classified into CR group. Those who did not participate in CR programs were classified into the non-CR group.
Kaplan-Meier survival analyses showed five-year survival rate of 96.9% in the CR group and 93.3% in the non-CR group. The hazard ratio (HR) for total 5-year mortality in the CR group was approximately 0.41 (95% CI: 0.27-0.63) times that of the non-CR group, indicating a reduction in the risk of mortality by approximately 59% in propensity score weighted cohort of 1878 patients. The HR for major adverse cardiac events (MACE) with respect to 5-year mortality, MI recurrence, revascularization, and readmission due to cardiovascular disease in CR group was 0.96 times that of non-CR group (95% CI: 0.83-1.12), without significant difference between the two groups.
In this study, 5-year mortality decreased by 59% in patients with AMI who had participated in CR compared to those who did not.
This finding should be very helpful in emphasizing the need for CR in a country like Korea where CR has not yet been actively implemented.
在一些欧洲和亚洲国家,包括韩国,心脏康复(CR)的参与率仍然很低。
调查 CR 对急性心肌梗死(AMI)患者预后改善的影响,包括复发、再入院、血运重建和死亡率。
回顾性队列研究。
韩国 11 家三级医院(ETHIK 研究)。
2012 年 1 月至 2015 年 12 月共收集了 7299 例患者的数据,其中 7136 例患者的数据与保险索赔数据相关联。最终分析纳入了 6743 例患者。
接受门诊治疗时参加 CR 计划的患者被分为 CR 组。未参加 CR 计划的患者被分为非 CR 组。
Kaplan-Meier 生存分析显示,CR 组患者的 5 年生存率为 96.9%,非 CR 组为 93.3%。CR 组的总 5 年死亡率的危险比(HR)约为非 CR 组的 0.41(95%可信区间:0.27-0.63),表明在倾向评分加权的 1878 例患者队列中,死亡率风险降低了约 59%。CR 组与非 CR 组相比,5 年死亡率、心肌梗死复发、血运重建和心血管疾病再入院的主要不良心脏事件(MACE)的 HR 为 0.96(95%可信区间:0.83-1.12),两组间无显著差异。
在这项研究中,与未参加 CR 的 AMI 患者相比,参加 CR 的患者 5 年死亡率降低了 59%。
在韩国等尚未积极开展 CR 的国家,这一发现对于强调 CR 的必要性非常有帮助。